Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Tuesday's Intraday Session

 

Gainers

  • Jaguar Health (NASDAQ:JAGX) shares increased by 58.26% to $1.82 during Tuesday's regular session. Trading volume for this security as of 12:30 EST is 28.4 million, which is 1576.32% of its average full-day volume over the last 100 days. The company's market cap stands at $83.8 million.
  • Biofrontera (NASDAQ:BFRI) stock rose 43.17% to $10.91. As of 12:30 EST, Biofrontera's stock is trading at a volume of 64.9 million, which is 215.98% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $157.7 million.
  • Aridis Pharmaceuticals (NASDAQ:ARDS) shares rose 25.95% to $3.2. Trading volume for Aridis Pharmaceuticals's stock is 34.5 million as of 12:30 EST. This is 84459.21% of its average full-day volume over the last 100 days. The company's market cap stands at $44.9 million.
  • Evofem Biosciences (NASDAQ:EVFM) shares increased by 22.36% to $0.45. Trading volume for Evofem Biosciences's stock is 9.5 million as of 12:30 EST. This is 318.22% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $74.0 million.
  • Quantum-Si (NASDAQ:QSI) stock moved upwards by 22.27% to $7.74. Trading volume for Quantum-Si's stock is 5.1 million as of 12:30 EST. This is 709.8% of its average full-day volume over the last 100 days. The company's market cap stands at $1.0 billion.
  • Cassava Sciences (NASDAQ:SAVA) shares increased by 19.85% to $44.07. As of 12:30 EST, Cassava Sciences's stock is trading at a volume of 13.7 million, which is 236.68% of its average full-day volume over the last 100 days. The company's market cap stands at $1.7 billion.
  •  

Losers

  • Aldeyra Therapeutics (NASDAQ:ALDX) stock fell 50.92% to $3.5 during Tuesday's regular session. Trading volume for this security as of 12:30 EST is 7.3 million, which is 1081.06% of its average full-day volume over the last 100 days. The company's market cap stands at $203.3 million.
  • CytomX Therapeutics (NASDAQ:CTMX) shares decreased by 41.32% to $3.79. As of 12:30 EST, this security is trading at a volume of 7.9 million shares, making up 995.72% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $246.9 million.
  • DBV Technologies (NASDAQ:DBVT) stock declined by 40.75% to $1.6. As of 12:30 EST, this security is trading at a volume of 12.4 million shares, making up 4295.91% of its average full-day volume over the last 100 days. The company's market cap stands at $175.9 million.
  • Aquestive Therapeutics (NASDAQ:AQST) stock decreased by 33.13% to $4.16. As of 12:30 EST, this security is trading at a volume of 3.2 million shares, making up 536.42% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $167.0 million.
  • ACADIA Pharmaceuticals (NASDAQ:ACAD) stock fell 19.53% to $21.8. Trading volume for ACADIA Pharmaceuticals's stock is 4.3 million as of 12:30 EST. This is 296.23% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $3.5 billion.
  • Vir Biotechnology (NASDAQ:VIR) stock decreased by 15.27% to $43.35. As of 12:30 EST, this security is trading at a volume of 2.1 million shares, making up 148.38% of its average full-day volume over the last 100 days. The company's market cap stands at $5.6 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.